Skip to the main content

Review article

Pharmacoeconomics and its Importance in the Choice of Antidepressants

Vlado Jukić
Miroslav Herceg


Full text: croatian pdf 68 Kb

page 113-118

downloads: 916

cite


Abstract

This Article shows the theoretical
approaches of a new interdiciplinary branch, i.e. pharmacoeconomics.
The development of pharmacoeconomics
results from the galloping increase in healthcare costs. The
two key components of pharmacoeconomic evaluation are
costs (price) and benefits. The basic methods of pharmacoeconomic
analysis are: Cost-Minimalisation Analysis
(CMA), Cost-Benefit Analysis (CBA), Cost-Effectiveness
Analysis (CEA) and Cost-Utility Analysis (CUA). Until a few
years ago not many people were engaged in pharmacoeconomics.
The increase in drug prices, the reduction of
resources and the increased patient education increasingly
require the research in the field of pharmacoeconomics.

Keywords

pharmacoeconomics; antidepressants; costs; benefit

Hrčak ID:

19813

URI

https://hrcak.srce.hr/19813

Publication date:

26.1.2004.

Article data in other languages: croatian

Visits: 2.144 *